Voriconazole Injection, Powder, Lyophilized, For Solution
Product Images NDC 70436-029

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 70436-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Voriconazole01

Chemical structure diagram of voriconazole, illustrating the arrangement of rings and functional groups including fluorine atoms and methyl groups in the molecule.*

FDA Label Image

Voriconazole02

Label for Voriconazole for Injection 200 mg per vial, a sterile lyophilized powder for intravenous infusion by Slate Run Pharmaceuticals. The label includes dosage preparation instructions, storage conditions (15° to 30°C), and manufacturer details noting production by Hainan Poly Pharm. Co., Ltd. and distribution by Slate Run Pharmaceuticals. It highlights no natural rubber latex or preservatives.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.